Characteristics of behavioural addiction in Parkinson’s disease patients with self-reported impulse control disorder and controls matched for levodopa equivalent dose: a matched case–control study

Abstract

Impulse control disorders (ICD) in Parkinson’s disease (PD) frequently occur, not always as a direct consequence of dopaminergic medication. This study investigated premorbid personality traits and behavioural characteristics in non-demented PD patients with self-reported symptoms of ICD (PD-srICD). From a total of 200 non-demented PD patients who filled out questionnaires assessing symptoms and severity of ICD, those were classified as PD-srICD (n = 32) who reported current occurrence of at least one compulsive behaviour (gambling, sexual behaviour, buying behaviour, or eating). As a control group, 32 patients with no self-reported ICD symptoms were matched for levodopa equivalent daily dose. The demographic, clinical, and premorbid personality profiles were compared between both groups. Frequency of psychological characteristics indicating substance use disorder was evaluated in patients with PD-srICD. Patients with PD-srICD were more frequently male, younger at examination, had earlier PD onset, more depression, higher non-motor burden, less quality of life (p < 0.05, respectively), and more frequently reported premorbid sensation seeking/novelty orientation (p = 0.03) and joyful experience of stress (p = 0.04) than patients in the control group. Of patients with PD-srICD, 90.6% reported at least one behavioural characteristic of substance use disorder, most frequently positive expectations following ICD behaviour and illusional beliefs about its behavioural control. Signs of addiction were common among patients with PD-srICD. Therefore, the profile of psychological characteristics in patients with PD-srICD resembled that of patients with substance use disorder. It can be concluded that dopamine replacement therapy (DRT) alone does not account for PD-srICD and that thorough psychological diagnostics are recommended.

Bibliometric Cartography on Personality Traits and Stress: In Quest of Panaceas for Contemporary Workplace Challenges

“…It is widely known that personality traits are directly associated with the risk of dementia and Alzheimer's disease; however, it has also proven that certain personality traits strongly promotes stress and neural injury through plasma Glial Fibrillary Acidic Protein (GFAP). [17] Likewise, a clinical study has proven that certain personality traits can influence impulse control disorders among people affected by Parkinson's disease, [18] and traits such as higher neuroticism and lower extroversion have been seen as common among people suffering from Small Intestinal Bacterial Overgrowth (SIBO) syndrome, which causes stress and anxiety. [19] The secretion of stress hormones such as cortisol seems to be common among people with alexithymia, a personality trait that causes difficulties in social cognition.…”

Unveiling the Burden of Drug-Induced Impulsivity: A Network Analysis of the FDA Adverse Event Reporting System

“…Initially, it may manifest as heightened motivation and hobbyism, known as “honeymoon period” 16 . However, even when concealed in subclinical forms 17 , drug-induced impulsivity holds the potential to significantly erode patients’ QoL 18 . This erosion, appraised through metrics like the PDQ-39 scale 19 , encompasses diverse neuropsychiatric and somatic domains including mobility, daily activities, stigma, social support, communication 20 , urinary and sexual function, sleep, attention, and cardiovascular symptoms 21 .…”